Two new studies presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in ...

Two new studies being presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando shed light on how hereditary angioedema (HAE) – a rare, ...

October 17, 2012 (Boston, Massachusetts) — The risk of the potentially life-threatening side effect angioedema differs between different classes of drugs that inhibit the renin-angiotensin-aldosterone ...

Optimize your hereditary angioedema (HAE) care management with the help of an allergist-immunologist, PCP, gastroenterologist ...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced it will present Phase I data for BW-20805 at the American ...

Please provide your email address to receive an email when new articles are posted on . Patients fit into one of four groups based on monthly hereditary angioedema attacks before lanadelumab. Along ...

Hereditary angioedema (HAE) is a serious, potentially fatal disease of recurrent swelling of various subcutaneous and submucosal tissues throughout the body. Swelling is mediated by uncontrolled ...

Mammalian target of rapamycin (mTOR) is a serine/threonine kinase and regulates cellular metabolism, growth and proliferation. Sirolimus is an mTOR inhibitor and is widely used as an immunosuppressive ...

Please provide your email address to receive an email when new articles are posted on . Many patients with hereditary angioedema have poorly controlled disease ...

Angioedema diagnosis more often than not depends on the history of recent exposure to a triggering agent and presentation with typical clinical symptoms. There are some tests that may be prescribed to ...

Clinically validated biomarker assay has potential to eventually expand treatment opportunities of deucrictibant into additional forms of bradykinin-mediated angioedema Epidemiologic data and ...